• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患者的肠通透性:最新综合概述。

Intestinal permeability in type 1 diabetes: An updated comprehensive overview.

机构信息

The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen N, Denmark.

The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen N, Denmark.

出版信息

J Autoimmun. 2021 Aug;122:102674. doi: 10.1016/j.jaut.2021.102674. Epub 2021 Jun 25.

DOI:10.1016/j.jaut.2021.102674
PMID:34182210
Abstract

The etiopathogenesis of the autoimmune disease type 1 diabetes (T1D) is still largely unknown, however, both genetic and environmental factors contribute to the development of the disease. A major contact surface for environmental factors is the gastrointestinal (GI) tract, where barrier defects in T1D likely cause diabetogenic antigens to enter the body tissues, contributing to beta-cell autoimmunity. Human and animal research imply that increased intestinal permeability is an important disease determinant, although the underlying methodologies, interpretations and conclusions are diverse. In this review, an updated comprehensive overview on intestinal permeability in patients with T1D and animal models of T1D is provided in the categories: in vivo permeability, ex vivo permeability, zonulin, molecular permeability and blood markers. Across categories, there is consistency pointing towards increased intestinal permeability in T1D. In animal models of T1D, the intestinal permeability varies with age and strains implying a need for careful selection of method and experimental setup. Furthermore, dietary interventions that affect diabetes incidence in animal models does also impact the intestinal permeability, suggesting an association between increased intestinal permeability and T1D development.

摘要

自身免疫性疾病 1 型糖尿病(T1D)的发病机制仍不清楚,但遗传和环境因素都有助于该病的发生。环境因素的一个主要接触表面是胃肠道(GI)道,在 T1D 中,屏障缺陷可能导致致糖尿病抗原进入身体组织,导致β细胞自身免疫。人体和动物研究表明,肠道通透性增加是一个重要的疾病决定因素,尽管其潜在的方法、解释和结论是多种多样的。在这篇综述中,提供了 T1D 患者和 T1D 动物模型中肠道通透性的最新综合概述,分为:体内通透性、离体通透性、紧密连接蛋白、分子通透性和血液标志物。在各个类别中,都有一致性表明 T1D 患者的肠道通透性增加。在 T1D 的动物模型中,肠道通透性随年龄和菌株而变化,这意味着需要仔细选择方法和实验设置。此外,影响动物模型中糖尿病发病率的饮食干预也会影响肠道通透性,这表明肠道通透性增加与 T1D 发展之间存在关联。

相似文献

1
Intestinal permeability in type 1 diabetes: An updated comprehensive overview.1 型糖尿病患者的肠通透性:最新综合概述。
J Autoimmun. 2021 Aug;122:102674. doi: 10.1016/j.jaut.2021.102674. Epub 2021 Jun 25.
2
Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.胰高血糖素样肽-2可降低肠道通透性,但不会改变非肥胖糖尿病小鼠1型糖尿病的发病情况。
Endocrinology. 2009 Feb;150(2):592-9. doi: 10.1210/en.2008-1228. Epub 2008 Oct 9.
3
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.调节肠道 ILC3 治疗 1 型糖尿病。
Front Immunol. 2021 Jun 3;12:653560. doi: 10.3389/fimmu.2021.653560. eCollection 2021.
4
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.肠道屏障完整性的丧失会触发胰岛反应性 T 细胞的激活和自身免疫性糖尿病。
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15140-15149. doi: 10.1073/pnas.1814558116. Epub 2019 Jun 10.
5
Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients.循环中zonulin与乳糜泻患者小肠黏膜中肠道病毒密度及耐受性树突状细胞相关。
Dig Dis Sci. 2017 Feb;62(2):358-371. doi: 10.1007/s10620-016-4403-z. Epub 2016 Dec 19.
6
Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes.1型糖尿病发病前生物繁殖大鼠肠道形态和通透性的变化。
J Pediatr Gastroenterol Nutr. 2005 May;40(5):589-95. doi: 10.1097/01.mpg.0000159636.19346.c1.
7
Lower expression of tight junction protein 1 gene and increased FOXP3 expression in the small bowel mucosa in coeliac disease and associated type 1 diabetes mellitus.在乳糜泻和相关的 1 型糖尿病患者的小肠黏膜中,紧密连接蛋白 1 基因的表达降低,FOXP3 表达增加。
Int Arch Allergy Immunol. 2011;156(4):451-61. doi: 10.1159/000324456. Epub 2011 Aug 10.
8
The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?肠道通透性在1型糖尿病发病机制中的作用——一个确凿还是有漏洞的概念?
Pediatr Diabetes. 2015 Nov;16(7):485-92. doi: 10.1111/pedi.12305. Epub 2015 Aug 13.
9
Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice.肠道通透性的空间变化与非肥胖型糖尿病小鼠 1 型糖尿病的发展有关。
BMJ Open Diabetes Res Care. 2019 Dec 15;7(1):e000793. doi: 10.1136/bmjdrc-2019-000793. eCollection 2019.
10
Role of the gastrointestinal ecosystem in the development of type 1 diabetes.胃肠道生态系统在1型糖尿病发生发展中的作用。
Pediatr Diabetes. 2015 Sep;16(6):407-18. doi: 10.1111/pedi.12282. Epub 2015 May 8.

引用本文的文献

1
Impact of Parabacteroides distasonis colonization on host microbiome, metabolome, immunity, and diabetes onset.狄氏副拟杆菌定殖对宿主微生物组、代谢组、免疫及糖尿病发病的影响。
J Mol Endocrinol. 2025 Aug 28;75(2). doi: 10.1530/JME-25-0025. Print 2025 Aug 1.
2
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes.从微生物到代谢产物:1型糖尿病肠道微生物组研究进展
Metabolites. 2025 Feb 19;15(2):138. doi: 10.3390/metabo15020138.
3
Assessment of Immobilized OLXAL-1 Cells on Oat Flakes for Functional Regulation of the Intestinal Microbiome in a Type-1 Diabetic Animal Model.
在1型糖尿病动物模型中,评估燕麦片上固定化的OLXAL-1细胞对肠道微生物群的功能调节作用。
Foods. 2024 Dec 20;13(24):4134. doi: 10.3390/foods13244134.
4
Intestinal mucosal immunity and type 1 diabetes: Non-negligible communication between gut and pancreas.肠道黏膜免疫与1型糖尿病:肠道与胰腺之间不可忽视的相互作用
Diabetes Obes Metab. 2025 Mar;27(3):1045-1064. doi: 10.1111/dom.16101. Epub 2024 Dec 1.
5
Development and application of a multi-sugar assay to assess intestinal permeability.一种用于评估肠道通透性的多糖检测方法的开发与应用。
Bioanalysis. 2024;16(16):849-861. doi: 10.1080/17576180.2024.2374168. Epub 2024 Jul 18.
6
Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10 Breg cells and protect against T1D.B 细胞特异性 TLR9 缺陷 NOD 小鼠的肠道微生物群可促进 IL-10 Breg 细胞并预防 T1D。
Front Immunol. 2024 Jun 6;15:1413177. doi: 10.3389/fimmu.2024.1413177. eCollection 2024.
7
Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk.携带HLA相关1型糖尿病风险的母婴二元组血清蛋白质组学
iScience. 2024 May 22;27(6):110048. doi: 10.1016/j.isci.2024.110048. eCollection 2024 Jun 21.
8
Type 1 diabetes human enteroid studies reveal major changes in the intestinal epithelial compartment.1 型糖尿病人类类器官研究揭示了肠道上皮隔室的重大变化。
Sci Rep. 2024 May 24;14(1):11911. doi: 10.1038/s41598-024-62282-x.
9
Emerging role of gut microbiota in autoimmune diseases.肠道微生物群在自身免疫性疾病中的新兴作用。
Front Immunol. 2024 May 3;15:1365554. doi: 10.3389/fimmu.2024.1365554. eCollection 2024.
10
Landscape of the gut mycobiome dynamics during pregnancy and its relationship with host metabolism and pregnancy health.孕期肠道真菌组动态及其与宿主代谢和妊娠健康关系的研究进展。
Gut. 2024 Jul 11;73(8):1302-1312. doi: 10.1136/gutjnl-2024-332260.